# Acotec DCB Post Market Clinical Follow-up

> **NCT04393389** · — · RECRUITING · sponsor: **Acotec Scientific Co., Ltd** · enrollment: 3000 (estimated)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DEVICE:** AcoArt Orchid (0.035"), AcoArt Tulip (0.018") and AcoArt Litos (0.014") percutaneous transluminal angioplasty (PTA) paclitaxel drug coated balloon catheter manufactured by Acotec Scientific Co., Ltd.

## Key facts

- **NCT ID:** NCT04393389
- **Lead sponsor:** Acotec Scientific Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-06-04
- **Primary completion:** 2025-12-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04393389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04393389, "Acotec DCB Post Market Clinical Follow-up". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04393389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*